Jerome Belinson, MD

Kristine M. Zanotti, MD
Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Cleveland Clinic

Jerome Belinson, MD
The Taussig Cancer Center; Head, Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Cleveland Clinic  

Address: Kristine M. Zanotti, MD, Department of Obstetrics and Gynecology, A81, The Cleveland Clinic Foundation, 9500 Euclid Avenue,Cleveland, OH 44195; e-mail zanottk@ccf.org

Dr. Belinson has indicated he has received supplies and services from the Digene and Cytic corporations and is on the speakers’ bureau of Cytic Corporation.

Kristine M. Zanotti, MD
Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Cleveland Clinic

Jerome Belinson, MD
The Taussig Cancer Center; Head, Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Cleveland Clinic  

Address: Kristine M. Zanotti, MD, Department of Obstetrics and Gynecology, A81, The Cleveland Clinic Foundation, 9500 Euclid Avenue,Cleveland, OH 44195; e-mail zanottk@ccf.org

Dr. Belinson has indicated he has received supplies and services from the Digene and Cytic corporations and is on the speakers’ bureau of Cytic Corporation.

Kristine M. Zanotti, MD
Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Cleveland Clinic

Jerome Belinson, MD
The Taussig Cancer Center; Head, Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Cleveland Clinic  

Address: Kristine M. Zanotti, MD, Department of Obstetrics and Gynecology, A81, The Cleveland Clinic Foundation, 9500 Euclid Avenue,Cleveland, OH 44195; e-mail zanottk@ccf.org

Dr. Belinson has indicated he has received supplies and services from the Digene and Cytic corporations and is on the speakers’ bureau of Cytic Corporation.